Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
Completed
Henry Ford Hospital
Phase 4
2015-01-01
This is a Phase IV, randomized, double-blind, placebo-controlled, four-arm crossover study.
The study will assess the effects of a single dose of Silenor 6 mg compared with matching
placebo and a single dose of zolpidem 10 mg compared to its matching placebo at the
respective T-max in normal healthy adult male volunteers. The study will be conducted in
approximately 52 male subjects
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
Completed
Currax Pharmaceuticals
Phase 4
2015-01-01
This is a Phase IV, randomized, double-blind, placebo-controlled, four-arm crossover study.
The study will assess the effects of a single dose of Silenor 6 mg compared with matching
placebo and a single dose of zolpidem 10 mg compared to its matching placebo at the
respective T-max in normal healthy adult male volunteers. The study will be conducted in
approximately 52 male subjects
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
Completed
Pernix Theraputics LLC
Phase 4
2015-01-01
This is a Phase IV, randomized, double-blind, placebo-controlled, four-arm crossover study.
The study will assess the effects of a single dose of Silenor 6 mg compared with matching
placebo and a single dose of zolpidem 10 mg compared to its matching placebo at the
respective T-max in normal healthy adult male volunteers. The study will be conducted in
approximately 52 male subjects
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.